ETHYOL

Swiss trademark · 371850 · Word mark · In force

Register entry

Registration number
371850
Application number
02715/1989
Status
In force
Type
Word mark
Filed
Apr 7, 1989
Registered
Aug 21, 1989
Published
Sep 22, 1989
Protected until
Apr 7, 2029
Language of procedure
French
Source
Swissreg

Goods and services

Pharmaceuticals

Medizinische und pharmazeutische Präparate.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 3, 2023

    Agent removed

    Representative
    SEDIN SA, 24, rue Merle d'Aubigné, 1207 Genève (removed)

    Published in Swissreg on 03.10.2023

  2. Oct 3, 2023

    Transferred

    Owner
    Clinigen Limited, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom → CNX THERAPEUTICS LIMITED, 3 Bunhill Row, London, EC1Y 8YZ, United Kingdom
    Representative
    SEDIN SA, 24, Rue Merle d'Aubigné, 1207 Genève

    Published in Swissreg on 03.10.2023

  3. Sep 29, 2022

    Corrected

    Owner
    Clinigen Group LLC, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom → Clinigen Limited, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom

    Published in Swissreg on 29.09.2022

  4. Sep 27, 2022

    Holder’s address changed

    Owner
    Clinigen Group Plc, Pitcairn House, Crown Square, Centrum 100, Burton on Trent, Staffordshire DE14 2WW, United Kingdom → Clinigen Group LLC, Pitcairn House, Crown Square, First Ave, Burton-on-Trent, DE14 2WW, United Kingdom

    Published in Swissreg on 27.09.2022

  5. Mar 8, 2019

    Renewed

    Published in Swissreg on 08.03.2019

  6. Mar 5, 2019

    Agent removed

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)

    Published in Swissreg on 05.03.2019

  7. Mar 5, 2019

    Transferred

    Owner
    MedImmune, LLC, One MedImmune Way, Gaithersburg MD 20878, USA → Clinigen Group Plc, Pitcairn House, Crown Square, Centrum 100, Burton on Trent, Staffordshire DE14 2WW, United Kingdom
    Representative
    SEDIN SA, 24, rue Merle d'Aubigné, 1207 Genève

    Published in Swissreg on 05.03.2019

  8. Jan 21, 2009

    Renewed

    Published in Swissreg on 21.01.2009

4 earlier entries
  1. Jan 16, 2009

    Transferred

    Owner
    MedImmune Oncology, Inc., One Tower Bridge,, 100 Front Street, Suite 400, West Conshohocken, USA → MedImmune, LLC, One MedImmune Way, Gaithersburg MD 20878, USA
    Representative
    Kirker & Cie, Conseils en Marques SA, 14, rue du Mont-Blanc, 1201 Genève → Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex

    Published in Swissreg on 16.01.2009

  2. Nov 22, 2000

    Holder’s address changed

    Owner
    U.S. Bioscience, Inc., One Tower Bridge, 100 Front Street, West Conshohocken (PA), USA → MedImmune Oncology, Inc., One Tower Bridge,, 100 Front Street, Suite 400, West Conshohocken, USA

    Published in the SOGC no. 228 of 22.11.2000

  3. Nov 22, 1994

    Transferred

    Owner
    Sterling Drug Inc., 90 Park Avenue, New York (NY), USA → U.S. Bioscience, Inc., One Tower Bridge, 100 Front Street, West Conshohocken (PA), USA

    Published in the SOGC no. 227 of 22.11.1994

  4. Sep 22, 1989

    Registered

    Published in the SOGC no. 185 of 22.09.1989

Parties

Holder

CNX THERAPEUTICS LIMITED

3 Bunhill Row, London, EC1Y 8YZ, GB

Agent

Sedin SA

SEDIN SA

24, Rue Merle d'Aubigné, 1207 Genève

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.